It has been well documented that most of the Schistosoma candidate vaccines are poorly immunogenic. I wish to know the factors that are responsible for this poor immunogenicity of the parasite antigens and which have limited the success of arriving at more efficacious vaccines bearing in mind the biology of the parasites and host cells that mediate immunity. I will appreciate your contributions and materials for further reading

Similar questions and discussions